Biotech News
Hoth Therapeutics Partners with OnTargetx to Advance Cancer Therapy HT-KIT
Hoth Therapeutics Inc., a biopharmaceutical company focused on developing therapies for unmet medical needs, has announced a collaboration with OnTargetx R&D Inc. to further research on its cancer-fighting candidate, HT-KIT. The study represents a key phase in the preclinical development
11 February 2025